Patents by Inventor Praveen Kumar Pogula

Praveen Kumar Pogula has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Napthalimide-benzimidazole hybrids as potential antitumor agents and process for the preparation thereof
    Patent number: 8288387
    Abstract: The present invention provides the compounds of general formula 5 and 9 useful as potential antitumour agents against human cancer cell lines. The present invention further provides the process for preparation of napthalimide-benzimidazole hybrids of general formula 5 and 9, n-1-2, R=n-methylpiperazine or morpholine (Formula 9), wherein: n=2-3, m=2-3 and R=n-methylpiperazine or morpholine.
    Type: Grant
    Filed: March 3, 2009
    Date of Patent: October 16, 2012
    Assignee: Council of Scientific & Industrial Research
    Inventors: Kamal Ahmed, Praveen Kumar Pogula
  • Phenanthrylphenol linked pyrrolo [2, l-] [l, 4] benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
    Patent number: 8217167
    Abstract: The present invention provides a compounds of general formula (6), useful as potential antitumour agents against human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2,1-c][1,4]benzodiazepine hybrids of general formula (6).
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: July 10, 2012
    Assignee: Council of Scientific & Industrial Research
    Inventors: Kamal Ahmed, Sreekanth Kokkonda, Praveen Kumar Pogula, Balakishan Gorre
  • NEW PHENANTHRYLPHENOL LINKED PYRROLO [2, L-C] [L, 4] BENZODIAZEPINE HYBRIDS AS POTENTIAL ANTITUMOUR AGENTS AND PROCESS FOR THE PREPARATION THEREOF
    Publication number: 20110207924
    Abstract: The present invention provides a compounds of general formula (6), useful as potential antitumour agents against human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2,1-c][1,4]benzodiazepine hybrids of general formula (6).
    Type: Application
    Filed: March 12, 2009
    Publication date: August 25, 2011
    Applicant: Council of Scientific & Industrial Research
    Inventors: Kamal Ahmed, Sreekanth Kokkonda, Praveen Kumar Pogula, Balakishan Gorre
  • NOVEL NAPTHALIMIDE-BENZIMIDAZOLE HYBRIDS AS POTENTIAL ANTITUMOR AGENTS AND PROCESS FOR THE PREPARATION THEREOF
    Publication number: 20110166346
    Abstract: The present invention provides the compounds of general formula 5 and 9 useful as potential antitumour agents against human cancer cell lines. The present invention further provides the process for preparation of napthalimide-benzimidazole hybrids of general formula 5 and 9, n-1-2, R=n-methylpiperazine or morpholine (Formula 9), wherein: n=2-3, m=2-3 and R=n-methylpiperazine or morpholine.
    Type: Application
    Filed: March 3, 2009
    Publication date: July 7, 2011
    Inventors: Kamal Ahmed, Praveen Kumar Pogula
  • C8—linked pyrrolo[2,1-c][1,4]benzodiazepine-acridone/acridine hybrids
    Patent number: 7056913
    Abstract: The present invention provides novel pyrrolo-[2,1-c][1,4]benzodiazepine hybrids useful as anti-tumour agents and a process for the preparation thereof.
    Type: Grant
    Filed: March 30, 2004
    Date of Patent: June 6, 2006
    Assignee: Council of Scientific and Industrial Research
    Inventors: Ahmed Kamal, Srinivas Olepu, Ramulu Poddutoori, Ramesh Gujjar, Praveen Kumar Pogula